Trending Articles

  1. Hovione announces leadership transition and interim Co-CEO structure Co-CEOs for the transition period, António Almeida and Dr. Marco Gil, bring combined 40 years of experience with Hovione to their new role
  2. Cambridge biotech Verinnogen secures £500k CPI investment to advance cancer drug development The investment will advance a handheld device delivering more precise and reproducible tumour size measurements in preclinical oncology research, addressing variability in...
  3. Adragos Pharma appoints Kostas Rengis as Chief Executive Officer Munich, Germany – May 7th, 2026 – Adragos Pharma, a global contract development and manufacturing organisation (CDMO), today announced the appointment of Konstantinos...
  4. Lonza delivers strong H1 2025 performance Lonza delivers strong H1 2025 performance and upgrades 2025 full-year CDMO sales and margin outlook
  5. Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to support...

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Manufacturing New platform leverages the established Curator platform methodology to industrialise Lentivirus processes from concept to clinic

Andelyn Biosciences launches LVV Curator platform, bringing proven viral vector platform pedigree to Lentiviral Vector manufacturing for cell therapies

Read more
Manufacturing Co-CEOs for the transition period, António Almeida and Dr. Marco Gil, bring combined 40 years of experience with Hovione to their new role

Hovione announces leadership transition and interim Co-CEO structure

Read more
Manufacturing The purchase will hand the Group a biologics drug substance manufacturing facility and a warehousing centre in Maryland, which Bora plans to use in cooperation with Tanvex...

Bora Group to acquire MacroGenics’ manufacturing operations and CDMO business

Read more
Finance The investment will advance a handheld device delivering more precise and reproducible tumour size measurements in preclinical oncology research, addressing variability in...

Cambridge biotech Verinnogen secures £500k CPI investment to advance cancer drug development

Read more
Manufacturing Munich, Germany – May 7th, 2026 – Adragos Pharma, a global contract development and manufacturing organisation (CDMO), today announced the appointment of Konstantinos...

Adragos Pharma appoints Kostas Rengis as Chief Executive Officer

Read more
Research & Development Abhijit Zutshi joins as CCO and Maninder Kapoor Puri as CHRO. India/U.S./UK, 1 May 2026: Syngene International, a global contract research, development, and manufacturing...

Syngene strengthens leadership team with two key appointments to support next phase of growth

Read more
Manufacturing Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to support...

Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair

Read more
Manufacturing The German biotech has announced it will cease production at its manufacturing sites in Germany and Singapore in its Q1 earnings report, cutting up to 22% of its workforce in...

BioNTech to cut up to 1860 jobs and end COVID vaccine production in Germany

Read more
Finance The firm has reported first-quarter earnings of $7.61bn and revenue of $15.17bn, both ahead of Wall Street forecasts, driven by robust GLP-1 sales and stronger-than-expected...

Novo Nordisk raises 2026 guidance after Wegovy pill drives stronger-than-expected Q1 earnings

Read more
Manufacturing The Cambridge and Macclesfield programmes, paused amid NHS reimbursement disputes, are back on track following the US-UK pharmaceutical deal and a revised NHS rebate rate

AstraZeneca resumes £300m UK investment as drug pricing and tariff landscape shifts

Read more
Finance The German chemicals giant posted solid volume growth across most segments in the first quarter of 2026, but adverse currency effects eroded sales and pushed EBITDA before...

BASF reports Q1 earnings as currency headwinds and Middle East conflict weigh on revenue

Read more
Finance In part one, Manufacturing Chemist explored the UK’s world-class science base and early-stage investment appeal. In this second instalment, attention turns to the structural...

Britain's biotech potential (part II): world-class science, second-class support?

Read more
Finance The firm will acquire Organon in an all-cash $11.75bn transaction, creating a larger global pharma group with expanded manufacturing capacity, stronger women's health...

Sun Pharma to acquire Organon in $11.75bn deal, expanding global manufacturing and biosimilars reach

Read more
Finance Total UK biotech equity financing reached £552m in the first quarter of 2026, driven by a 17% quarterly rise in venture capital investment, according to BioIndustry...

UK biotech venture capital rises 17% in Q1 2026 as deal activity surges 67% year-on-year, BIA figures show

Read more
Regulatory The UK produces top-tier life sciences research, offers favourable conditions for early-stage investment and hosts a growing network of internationally competitive clusters. So...

Britain's biotech potential (part I): world-class science, second-class support?

Read more
Research & Development The Innovate UK feasibility grant will advance its ZYLON programme, which involves clean-chemistry lab trials exploring how bio-derived materials could replace...

NEUVIOR Pharmaceuticals receives Innovate UK grant to explore bio-based materials for circular pharmaceutical manufacturing

Read more